Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade | BioSpace
Pictured: Teva’s site in Canada/iStock, JHVEPhoto Teva Pharmaceuticals on Tuesday announced that it has agreed to pay $750 million to put an end to what it calls a “historical income tax issue” in Israel. Under an agreement with the Israel Tax Authority, Teva will make its settlement payment in yearly installments, from 2024 to 2029. … Read more